Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancer
Xiangfeng Shen(First Bethune Hospital of Jilin University), Zhixiang Xu(Huazhong Agricultural University), Yuan Zhao(Henan University), Lihong Zhang(Jilin University), Yishu Wang(First Bethune Hospital of Jilin University), Hong-Lan Zhou(First Hospital of Jilin University), Jiyong Liang(The University of Texas MD Anderson Cancer Center), Jingjing Fan(Sun Yat-sen University), Yulin Li(University of Science and Technology of China), Guolong Liu(South China University of Technology)
Cited by 34
Related Papers
Spermidine coupled with exercise rescues skeletal muscle atrophy from D-gal-induced aging rats through enhanced autophagy and reduced apoptosis via AMPK-FOXO3a signal pathway
|Oncotarget|2017|177
Myristoylation confers noncanonical AMPK functions in autophagy selectivity and mitochondrial surveillance
|Nature Communications|2015|141
Recent advances in metal/covalent organic framework-based materials for photoelectrochemical sensing applications
|TrAC Trends in Analytical Chemistry|2022|133
Recent Findings in the Regulation of Programmed Death Ligand 1 Expression
|Frontiers in Immunology|2019|132
Novel chloramphenicol sensor based on aggregation-induced electrochemiluminescence and nanozyme amplification
|Biosensors and Bioelectronics|2021|130